EmitBio™ is a biotechnology company with products in the discovery, pre-clinical, and clinical stages of development. The Company’s proprietary technology platform uses precisely engineered light to stimulate physiological signals and initiate healing at the cellular level. While initially focused on an at-home treatment for COVID-19, EmitBio targets to deploy a family of products to redefine the standard of care for respiratory disease.
EmitBio Inc. is headquartered in Durham, North Carolina and is an operating subsidiary of KNOW Bio, LLC.
Company Details
- Employees
- 10
- Founded
- -
- Address
- 4222 Emperor Blvd.,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.emitbio.com
- Keywords
- Bedminster.
- HQ
- Durham, North Carolina
Emitbio Inc. Questions
Emitbio Inc.'s website is http://www.emitbio.com
Emitbio Inc.'s LinkedIn profile is https://www.linkedin.com/company/emitbio
Emitbio Inc. has
10 employees.
View email and phone details for 10
employees at Emitbio Inc..
Emitbio Inc.'s industry is
Biotechnology Research
Emitbio Inc.'s top competitors are
Know Bio, Llc,
Inventiva Pharma,
Viking Therapeutics, Inc.,
Galmed Pharmaceuticals Ltd.,
Vast Therapeutics,
Jubilant Clinsys,
Revian,
Intercept Pharmaceuticals,
Galectin Therapeutics,
Cymabay Therapeutics.
Emitbio Inc.'s categories are Biotechnology Research
Emitbio Inc.'s founding year is 2020
